| Soft drug design: general principles and recent applications N Bodor, P Buchwald Medicinal research reviews 20 (1), 58-101, 2000 | 349 | 2000 |
| Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours TA Ince, AD Sousa, MA Jones, JC Harrell, ES Agoston, M Krohn, ... Nature communications 6 (1), 7419, 2015 | 235 | 2015 |
| Recent advances in the brain targeting of neuropharmaceuticals by chemical delivery systems N Bodor, P Buchwald Advanced drug delivery reviews 36 (2-3), 229-254, 1999 | 233 | 1999 |
| Octanol-water partition: searching for predictive models P Buchwald, N Bodor Current medicinal chemistry 5 (5), 353-380, 1998 | 230 | 1998 |
| FEM-based oxygen consumption and cell viability models for avascular pancreatic islets P Buchwald Theoretical Biology and Medical Modelling 6 (1), 5, 2009 | 229 | 2009 |
| Oscillatory dynamics of Cdc42 GTPase in the control of polarized growth M Das, T Drake, DJ Wiley, P Buchwald, D Vavylonis, F Verde Science 337 (6091), 239-243, 2012 | 201 | 2012 |
| A local glucose-and oxygen concentration-based insulin secretion model for pancreatic islets P Buchwald Theoretical biology and medical modelling 8 (1), 20, 2011 | 178 | 2011 |
| Small‐molecule protein–protein interaction inhibitors: Therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations P Buchwald IUBMB life 62 (10), 724-731, 2010 | 175 | 2010 |
| Molecular size based approach to estimate partition properties for organic solutes N Bodor, P Buchwald The Journal of Physical Chemistry B 101 (17), 3404-3412, 1997 | 137 | 1997 |
| Ophthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems N Bodor, P Buchwald The AAPS journal 7 (4), 79, 2005 | 134 | 2005 |
| Methylene blue inhibits the SARS-CoV-2 spike–ACE2 protein-protein interaction–a mechanism that can contribute to its antiviral activity against COVID-19 D Bojadzic, O Alcazar, P Buchwald Frontiers in pharmacology 11, 600372, 2021 | 130 | 2021 |
| Small-molecule inhibitors of the coronavirus spike: ACE2 protein–protein interaction as blockers of viral attachment and entry for SARS-CoV-2 D Bojadzic, O Alcazar, J Chen, ST Chuang, JM Condor Capcha, ... ACS infectious diseases 7 (6), 1519-1534, 2021 | 128 | 2021 |
| Barriers to remember: brain-targeting chemical delivery systems and Alzheimer's disease N Bodor, P Buchwald Drug discovery today 7 (14), 766-774, 2002 | 118 | 2002 |
| Quantitative Structure− Metabolism Relationships: steric and nonsteric effects in the enzymatic hydrolysis of noncongener carboxylic esters P Buchwald, N Bodor Journal of medicinal chemistry 42 (25), 5160-5168, 1999 | 102 | 1999 |
| Organoid microphysiological system preserves pancreatic islet function within 3D matrix SN Patel, M Ishahak, D Chaimov, A Velraj, D LaShoto, DW Hagan, ... Science advances 7 (7), eaba5515, 2021 | 101 | 2021 |
| A simple, predictive, structure‐based skin permeability model P Buchwald, N Bodor Journal of Pharmacy and Pharmacology 53 (8), 1087-1098, 2001 | 100 | 2001 |
| Direct, differential‐equation‐based in‐vitro–in‐vivo correlation (IVIVC) method P Buchwald Journal of pharmacy and pharmacology 55 (4), 495-504, 2003 | 96 | 2003 |
| The food colorant erythrosine is a promiscuous protein–protein interaction inhibitor L Ganesan, E Margolles-Clark, Y Song, P Buchwald Biochemical pharmacology 81 (6), 810-818, 2011 | 94 | 2011 |
| Brain-targeted drug delivery: experiences to date N Bodor, P Buchwald American Journal of Drug Delivery 1 (1), 13-26, 2003 | 92 | 2003 |
| Concentration-dependency and time profile of insulin secretion: dynamic perifusion studies with human and murine islets O Alcazar, P Buchwald Frontiers in Endocrinology 10, 680, 2019 | 90 | 2019 |
Camillo RicordiUniversity of Miami, Director Diabetes Research Institute, Editor-in-Chief, www.CellR4.org,Verified email at miami.edu
